David R. Stevens, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 3,809 shares at $5.25 ($20K) on 2008-01-15, disclosed to the SEC on 2008-01-16.
Open-market purchase of $20k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |